IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

Q2 2018 vs Q3 2018

Comparing institutional holders between quarters

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Citadel Advisors LLC
NEW
Shares14,139
Change+14,139
Value$1
Filed 2019-05-15
UBS Group AG
INCREASED
Shares1,995 from 100
Change+1,895 (+1895%)
Value$0 ($0)
Filed 2018-11-14
Proequities, Inc.
NEW
Shares0
Change0
Value$0
Filed 2018-11-13
Anson Funds Management LPA
CLOSED
Shares0 from 117,187
Change-117,187 (-100%)
Value$0 (-$30)
Filed 2018-11-14
Sabby Management, LLC
CLOSED
Shares0 from 74,443
Change-74,443 (-100%)
Value$0 (-$1)
Filed 2018-11-14
Status
Citadel Advisors LLC
NEW14,139—+14,139——$1—2019-05-15
UBS Group AG
INCREASED1,995100+1,895+1895%$0$0$02018-11-14
Proequities, Inc.
NEW0—0——$0—2018-11-13
Anson Funds Management LPA
CLOSED0117,187-117,187-100%$30$0-$302018-11-14
Sabby Management, LLC
CLOSED074,443-74,443-100%$1$0-$12018-11-14
Showing 5 of 5 institutions